Amsterdam, 22 October 2009 – Dutch-based leading European stem cell storage bank, Cryo-Save Group N.V. (NYSE Euronext: CRYO) completed its listing on NYSE Euronext Amsterdam today.
Cryo-Save has storage and processing facilities in 5 countries and is operating in 38 countries in Europe, Asia and Africa. With over 115.000 samples stored, Cryo-Save is Europe’s largest adult stem cell storage bank. Cryo-Save shares trade on NYSE Euronext under the symbol 'CRYO' and are denominated in Euros. After opening, the first market price was €6.30 per share. Based on the total number of 9,639,191 shares the total market capitalization of the company at opening price was €60,726,903.
-
Listing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότεραSeamless listing, trading, clearing and settlement for fixed income
-
Trading
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότεραSeamless listing, trading, clearing and settlement for fixed income
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότεραSeamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeΔιαβάστε περισσότεραEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Διαβάστε περισσότεραThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indicesΔιαβάστε περισσότεραThis white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
- Regulation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Διαβάστε περισσότεραShaping capital markets for future generations